We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+14.65%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$296B
AUM Growth
+$30.5B
Cap. Flow
-$5.03B
Cap. Flow %
-1.7%
Top 10 Hldgs %
14.21%
Holding
9,236
New
1,125
Increased
3,977
Reduced
2,989
Closed
738

Sector Composition

Rank Sector Weight
1 Technology 10.93%
2 Financials 6.61%
3 Consumer Discretionary 6.23%
4 Healthcare 5.77%
5 Communication Services 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EIDX
6851
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$23K ﹤0.01%
171
+155
+969% +$13.7K
REV
6852
DELISTED
Revlon, Inc.
REV
$23K ﹤0.01%
1,970
+1,785
+965% +$16.3K
LIVKU
6853
DELISTED
LIV Capital Acquisition Corp. Unit
LIVKU
$23K ﹤0.01%
2,194
-6,510
-75% -$67.5K
APYX icon
6854
Apyx Medical
APYX
$173M
$22K ﹤0.01%
3,000
-2,000
-40% -$13.3K
ARCM icon
6855
Arrow Reserve Capital Management ETF
ARCM
$51M
$22K ﹤0.01%
215
+190
+760% +$19.1K
AVTX icon
6856
Avalo Therapeutics
AVTX
$965M
$22K ﹤0.01%
3
+2
+200% +$13.9K
CATX icon
6857
Perspective Therapeutics
CATX
$332M
$22K ﹤0.01%
4,983
+3,813
+326% +$16.8K
CCIF
6858
Carlyle Credit Income Fund
CCIF
$59.4M
$22K ﹤0.01%
2,208
-371
-14% -$3.7K
CETX icon
6859
Cemtrex
CETX
$4.25M
0
DAX icon
6860
Global X DAX Germany ETF
DAX
$230M
$22K ﹤0.01%
700
EEX
6861
DELISTED
Emerald Holding
EEX
$22K ﹤0.01%
4,120
+4,067
+7,674% +$15.1K
GSK icon
6862
PUT
GSK
GSK
$104B
$22K ﹤0.01%
+480
New +$22K
HOOK
6863
DELISTED
HOOKIPA Pharma
HOOK
$22K ﹤0.01%
201
+177
+738% +$19.1K
IPDN icon
6864
Professional Diversity Network
IPDN
$4.26M
$22K ﹤0.01%
+428
New +$10.8K
IPO icon
6865
Renaissance IPO ETF
IPO
$153M
$22K ﹤0.01%
346
-642
-65% -$37.9K
NTRL
6866
First Trust Equity Market Neutral ETF
NTRL
$16.3M
$22K ﹤0.01%
1,139
+440
+63% +$8.6K
MVO
6867
DELISTED
MV Oil Trust
MVO
$22K ﹤0.01%
7,038
-1,213
-15% -$3.34K
NOA
6868
North American Construction
NOA
$369M
$22K ﹤0.01%
2,233
+1,397
+167% +$12.2K
ONDS icon
6869
Ondas Inc
ONDS
$4.27B
$22K ﹤0.01%
+2,304
New +$16.1K
PLG
6870
Platinum Group Metals
PLG
$164M
$22K ﹤0.01%
4,677
+4,327
+1,236% +$12.5K
PWOD
6871
DELISTED
Penns Woods Bancorp
PWOD
$22K ﹤0.01%
+832
New +$20K
RFIL icon
6872
RF Industries
RFIL
$134M
$22K ﹤0.01%
4,318
+3,149
+269% +$15K
OLOX
6873
Olenox Industries
OLOX
$6.74M
$22K ﹤0.01%
+1
New +$18.1K
UCIB icon
6874
ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due Apr 5 2038
UCIB
$33M
$22K ﹤0.01%
1,415
-2
-0.1% -$28
VFVA icon
6875
Vanguard US Value Factor ETF
VFVA
$895M
$22K ﹤0.01%
283
-519
-65% -$37K

Similar funds

UBS Group's Q4 2020 Portfolio in Review

As of Q4 2020, UBS Group held 9,236 positions worth $296B, up 11% from $265B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group's Q4 2020 filing shows 1,125 new, 3,977 increased, 2,989 reduced and 738 closed positions. Its largest new stake was Vontier: 502,899 shares worth $16.8M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.91B.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.

  • UBS Group's largest Q4 2020 buy was Vontier: 502,899 shares worth $16.8M.
  • UBS Group added most to UBS Group in Q4 2020, an estimated $475M increase.
  • UBS Group's biggest Q4 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.91B.
  • UBS Group fully exited Delphi Technologies PLC Ordinary Shares in Q4 2020, selling an estimated $96.7M.
  • UBS Group's ten largest holdings make up 14% of its $296B portfolio in Q4 2020.
  • UBS Group opened 1,125 new positions and closed 738 in Q4 2020.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $296B.

Based on UBS Group's 13F filing for Q4 2020, filed 11 Feb 2021.